Metraipolis › archive › dc_666d854817eb
Ionic Liquid-Enabled Drug Delivery Systems: Benefits, Limitations, and Future Perspectives — Europe PMC PMID:41754965
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41754965
- DOI
- 10.3390/pharmaceutics18020224
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T23:08:37.259Z
- SHA-256 of the archived text
fcdbbef8223dc3646dce41034ddbf5c554d1e5853859886fe677f1658d59c72c- Stable URL of this page
https://metraipolis.com/documento/dc_666d854817eb
How to cite
Ionic Liquid-Enabled Drug Delivery Systems: Benefits, Limitations, and Future Perspectives — Europe PMC PMID:41754965 — Europe PMC (en), https://europepmc.org/article/MED/41754965 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_666d854817eb (Metraipolis archive dc_666d854817eb, sha256 fcdbbef8223dc3646dce41034ddbf5c554d1e5853859886fe677f1658d59c72c)
BibTeX
@misc{dc666d854817eb,
title = {Ionic Liquid-Enabled Drug Delivery Systems: Benefits, Limitations, and Future Perspectives — Europe PMC PMID:41754965},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41754965},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_666d854817eb; sha256 fcdbbef8223dc3646dce41034ddbf5c554d1e5853859886fe677f1658d59c72c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754965. Agents can read the archived copy with the MCP tool read_document.